Literature DB >> 26656572

Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.

Viktória Koroknai1, Szilvia Ecsedi, Laura Vízkeleti, Tímea Kiss, István Szász, Andrea Lukács, Orsolya Papp, Róza Ádány, Margit Balázs.   

Abstract

Malignant melanoma is one of the most aggressive human cancers. Invasion of cells is the first step in metastasis, resulting in cell migration through tissue compartments. We aimed to evaluate genomic alterations specifically associated with the invasive characteristics of melanoma cells. Matrigel invasion assays were used to determine the invasive properties of cell lines that originated from primary melanomas. Array comparative genomic hybridization analyses were carried out to define the chromosome copy number alterations (CNAs). Several recurrent CNAs were identified by array comparative genomic hybridization that affected melanoma-related genes. Invasive primary cell lines showed high frequencies of CNAs, including the loss of 7q and gain of 12q chromosomal regions targeting PTPN12, ADAM22, FZD1, TFPI2, GNG11, COL1A2, SMURF1, VGF, RELN and GLIPR1 genes. Gain of the GDNF (5p13.1), GPAA1, PLEC and SHARPIN (8q24.3) genes was significantly more frequent in invasive cell lines compared with the noninvasive ones. Importantly, copy number gains of these genes were also found in cell lines that originated from metastases, suggesting their role in melanoma metastasis formation. The present study describes genomic differences between invasive and noninvasive melanoma cell lines that may contribute toward the aggressive phenotype of human melanoma cells.

Entities:  

Mesh:

Year:  2016        PMID: 26656572     DOI: 10.1097/CMR.0000000000000227

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  6 in total

Review 1.  SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer's Disease?

Authors:  Dhanya Krishnan; Ramsekhar N Menon; Srinivas Gopala
Journal:  Cell Mol Neurobiol       Date:  2021-01-05       Impact factor: 5.046

2.  Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.

Authors:  Michelle L Chadwick; Adam Lane; Dana Thomas; Amanda R Smith; Angela R White; Dominique Davidson; Yuxin Feng; Elisa Boscolo; Yi Zheng; Denise M Adams; Anita Gupta; André Veillette; Lionel M L Chow
Journal:  Oncotarget       Date:  2018-05-15

3.  Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.

Authors:  Vikas Patel; István Szász; Viktória Koroknai; Tímea Kiss; Margit Balázs
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

4.  Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.

Authors:  Tímea Kiss; Krisztina Jámbor; Viktória Koroknai; István Szász; Helga Bárdos; Attila Mokánszki; Róza Ádány; Margit Balázs
Journal:  Pathol Oncol Res       Date:  2021-03-05       Impact factor: 3.201

Review 5.  The GDNF Family: A Role in Cancer?

Authors:  Graeme C Fielder; Teresa Wen-Shan Yang; Mahalakshmi Razdan; Yan Li; Jun Lu; Jo K Perry; Peter E Lobie; Dong-Xu Liu
Journal:  Neoplasia       Date:  2017-12-12       Impact factor: 5.715

6.  Progress in the correlation between PTPN12 gene expression and human tumors.

Authors:  Yu-Hu Huo; Ya-Ni Wang; Ling-Bing Meng; Ai-Li Zhang; Bin Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.